Development of Therapeutics for DENGUE VIRUS
Development of Therapeutics for DENGUE VIRUS
登革热病毒治疗方法的开发
批准号：
10938081
负责人：
金额：
$175.3万
依托单位：
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
项目状态：
已结题
起止时间：
2023-09-25 至 2024-06-24
关键词：
Advanced DevelopmentCategoriesChemistryClinicalDengue VirusDevelopmentEmerging Communicable DiseasesNational Institute of Allergy and Infectious DiseasePathway interactionsefficacy evaluationmanufacturepre-clinicalpriority pathogenproduct developmentresearch and developmentsafety assessmenttherapeutic candidatetherapeutic development
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To support the advanced development of a promising candidate therapeutic for NIAID Category A, B, and C Priority Pathogens or emerging infectious diseases. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
